Intertek Melbourn

A leading provider of pharmaceutical analysis and formulation support with 30+ years of experience in inhaled product development and Good Manufacturing Practice (GMP) compliant analytical testing and stability storage services. We have a reputation for providing outstanding and responsive customer service. Previously known as Melbourn Scientific Ltd, the laboratory, based near Cambridge UK, was acquired by Intertek in 2013. We opened a second facility in 2015 and another in 2019 leading to further expansion which has doubled our laboratory footprint. We have specialist skills and experience in analytical testing and formulation for inhaled and intranasal products as well as all...

Method development,method validation,analytical support,accelerated feasibility studies,formulation,product development,raw material testing,qc and finished product testing,inhaled product testing,stability studies and storage,inhaled medicine development,formulation development,inhalation product analysis and testing,dissolution testing,inhaled medicine product characterisation ,clinical trial gmp manufacture,pharmaceutical qc testing,nasal drug products,mdrs,pharmaceutical analytical services,biologics formulation,drug delivery development,nebulised drug delivery,inhaled vaccine delivery,repurposing drugs for oindp delivery,in vitro bioequivalence testing,cmc development support,intranasal drug development,ich stability storage,pharmaceutical stability testing,dry powder inhaler development,pmdi development,aerodynamic particle / droplet size distribution,delivered dose uniformity,particle size or droplet size,spray pattern / plume geometry,powder and particle characterization,product characterization studies,ivbe studies,clinical & finished product release testing,mdrs particle studies,drug repurposing for oindp administration,device compatibility studies,device verification testing,patient in-use / misuse studies,photostability studies,comparator studies,dissolution testing,in vitro bioequivalence (ivbe) studies,ivbe studies,realistic flow profiles,pressurized metered dose inhalers (pmdi) development,soft mist inhaler development,laser particle and droplet sizing,sub-visible particle determination,and inhaled and nasal biologic drug development

Intertek melbourn operates in the Pharmaceutical manufacturing industry.

Intertek melbourn's revenue is 11m - 100m

Intertek melbourn has 51 - 200 employees.